Regulatory perspectives on probiotics and microbiome products
Atte von Wright, Scientific Advisor, Professor, Biosafe
In this webinar series, Biosafe brings a scientific and regulatory perspective to the evolving microbiome landscape. We explore what current research really tells us, where uncertainties remain, and what companies need to consider when developing and introducing new probiotic, prebiotic, or postbiotic formulations for food, feed, or supplements.
Webinar recording 3/3: Regulatory perspectives on probiotics and microbiome products
How products targeting the microbiome are classified, assessed, and authorised.
-
Foods, novel foods or pharmaceuticals? Regulatory positioning
-
Health claims in the EU: what is allowed and why
-
When is a product considered a novel food?
-
How the safety of a probiotic is assessed in practice
